Zimmer Biomet Holdings, Inc. (NYSE:ZBH) reported third-quarter adjusted earnings of $1.90 per share, up 9.2% year over year, beating the Street estimates of $1.87.

The orthopedic implant maker reported sales of $2.001 billion, up 7% on a reported basis, up 5.4% on a constant currency basis, and 2.8% on an organic constant currency basis, almost in line with the consensus of $2.005 billion.

Knee product sales increased 6.3% to $792.4 million (+5.3% organically), and hip product sales increased 5.1% (+3.8%) to $506.2 million.

Sports Medicine products generated sales of $541.5 million, up 19.2% (+3.6%).

Technology & Data, Bone Cement, and ...